Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.
Pemmaraju, Naveen; Lane, Andrew A; Sweet, Kendra L; Stein, Anthony S; Vasu, Sumithira; Blum, William; Rizzieri, David A; Wang, Eunice S; Duvic, Madeleine; Sloan, J Mark; Spence, Sharon; Shemesh, Shay; Brooks, Christopher L; Balser, John; Bergstein, Ivan; Lancet, Jeffrey E; Kantarjian, Hagop M; Konopleva, Marina.
N Engl J Med
; 380(17): 1628-1637, 2019 04 25.
Artigo em Inglês | MEDLINE | ID: mdl-31018069
Patient and central venous catheter related risk factors for blood stream infections in children receiving chemotherapy.
Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia.
Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial.
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan.
Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin
Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival.
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia.
Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group.
Cellular and plasma nitrite levels in myeloid leukemia: a pathogenetic decrease.
Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.